A major factor towards the development of Parkinson’s disease (PD) is the inability of certain organelles to clear misfolded proteins, making this process a particularly desirable target for new treatments. Jeffrey Kordower, PhD from Rush University Medical Center, Chicago, IL, gives us some examples of therapeutic strategies currently being examined which aim to restore clearance in PD patients. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) held in London, UK.

свернуть